A curious feature of axial disease in ankylosing spondylitis (AS) and related non-
radiographic axial spondyloarthropathy (nrAxSpA) is that spinal inflammation may ultimately …

Despite increasing availability of treatments for spondyloarthritis (SpA) including tumour
necrosis factor (TNF) and interleukin-17 (IL-17) inhibitors, there is no established treatment …

Progressive understanding of the underlying pathophysiology of axial spondyloarthritis has
successfully translated into innovative therapeutic strategies and successful management of …

Over the recent years the wider availability and application of state-of-the-art immunological
technologies greatly advanced the insight into the mechanisms that play an important role in …

Ankylosing spondylitis (AS) is a progressive common autoimmune inflammatory disease,
part of the spondylarthritis group, characterized, besides clinical spinal and peripheral joint …

Abstract Purpose of Review Recognition of the importance of enthesitis as the pivotal
pathological process underpinning spondyloarthropathies (SpA) has increased in recent …

The inflammatory disorders collectively termed the seronegative spondyloarthropathies
(SpA) include ankylosing spondylitis (AS), psoriatic arthritis (PsA), reactive arthritis, the …

The Spondyloarthritis Research and Therapy Network (SPARTAN), founded in 2003 to
promote research, education, and treatment of ankylosing spondylitis (AS) and related forms …

Abstract Purpose of Review Enthesitis is a cardinal feature of spondyloarthritis (SpA).
Despite increasing available treatments, challenges remain in adequately controlling …

Spondyloarthritis (SpA) is characterized by the infiltration of innate and adaptive immune
cells into entheses and bone marrow. Molecular, cellular and imaging evidence …